Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report

We report here a 66-year-old woman diagnosed with bronchioloalveolar carcinoma of the right lung cT4N2M0. The patient was from the Philippines, had never smoked, and tested positive for an EGFR mutation. She received gefitinib as neoadjuvant therapy for two months and displayed a partial response. T...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: López-González, A., Almagro, E., Salas, C., Varela, A., Provencio, M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2013
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3949555/
https://ncbi.nlm.nih.gov/pubmed/26029620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2013.02.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller